Coronavirus: UK will achieve ‘Herd Immunity’ on April 12, Study finds

The United Kingdom, who has vaccinated more than half of its adult population against coronavirus, it will reach “herd immunity” on April 12, according to calculations by University College London (UCL, in English) published this Thursday.

According to these analyzes, the protection of the population against coronavirusEither through vaccination or because the disease has been overcome, it will reach 73.4% of the population on April 12, the date of the second phase of the de-escalation.

That percentage, according to the experts from that university, is enough to say that there is “herd immunity”, also known as herd or group immunity, which occurs when a sufficient number of individuals are protected against a certain infection and act as Firewalls by preventing the virus from reaching the unprotected.

According to the latest official figures, more than 31 million people have received the first dose of a vaccine against covid-19 and more than five million the second dose.

The expert Karl Friston, from the UCL, highlighted the level of immunity of the population given that “more than 50% of adults have been vaccinated” and a high percentage “have been exposed to the virus.”

The newspaper “The Daily Telegraph”, which has had access to this UCL study, highlighted the effectiveness of the model used by this university because it records deaths, infections, vaccinations and hospitalizations in real time.

Next Monday begins the second phase of the de-escalation in England, with the reopening of non-essential shops, hairdressers, beauty salons or gyms.

The first phase began on March 29 when the recommendation not to leave home unless for essential matters was ended, while the third phase is scheduled for May 17, with the resumption of international flights.

The UK is vaccinating with the BioNTech / Pfizer and Oxford / AstraZeneca preparations, while Wales started immunizing this week with Moderna.

However, British regulators recommended yesterday not to use the AstraZeneca vaccine for those under 30 years of age due to the possible link between the preparation and reduced cases of thrombi.